Prognostic and predictive roles of cancer stem cell markers in head and neck squamous cell carcinoma patients receiving chemoradiotherapy with or without nimotuzumab

No abstract is available for this paper.

• Publication year

  2022

• Venue

  British Journal of Cancer

• Publication date

  2022-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41416-022-01730-9PMID 35140342PMCID PMC9091234
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas

  2020cited by this paper
• Prognostic and predictive significance of nuclear HIF1α expression in locally advanced HNSCC patients treated with chemoradiation with or without nimotuzumab

  2020cited by this paper
• Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis

  2019cited by this paper
• Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer

  2019cited by this paper
• Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

  2019cited by this paper
• The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity

  2019cited by this paper
• The changing therapeutic landscape of head and neck cancer

  2019cited by this paper
• A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer

  2019cited by this paper
• Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

  2019cited by this paper
• Efficacy and safety of anti‐EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic review and meta‐analysis of randomized controlled trials

  2018cited by this paper
• High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma

  2018cited by this paper
• Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer

  2018cited by this paper
• SOX2 activation predicts prognosis in patients with head and neck squamous cell carcinoma

  2018cited by this paper
• Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis

  2017cited by this paper
• Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2

  2017cited by this paper
• Hypoxia regulates CD44 expression via hypoxia-inducible factor-1α in human gastric cancer cells.

  2017cited by this paper
• CD44: A Multifunctional Cell Surface Adhesion Receptor Is a Regulator of Progression and Metastasis of Cancer Cells

  2017cited by this paper
• Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(−) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

  2016cited by this paper
• OCT4 Acts as an Integrator of Pluripotency and Signal-Induced Differentiation.

  2016cited by this paper
• Low prevalence of transcriptionally active human papilloma virus in Indian patients with HNSCC and leukoplakia.

  2016cited by this paper
• Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma

  2016cited by this paper
• CD98 as a novel prognostic indicator for patients with stage III/IV hypopharyngeal squamous cell carcinoma

  2015cited by this paper
• Loss of SOX2 expression induces cell motility via vimentin up‐regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma

  2015cited by this paper
• Oct4 is a critical regulator of stemness in head and neck squamous carcinoma cells

  2014cited by this paper
• Prognostic significance of SOX2 in head and neck cancer: a meta-analysis.

  2014cited by this paper
• Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.

  2014cited by this paper
• Expression and role of the embryonic protein SOX2 in head and neck squamous cell carcinoma.

  2014cited by this paper
• CD44 interacts with EGFR and promotes head and neck squamous cell carcinoma initiation and progression.

  2013cited by this paper
• CD98 marks a subpopulation of head and neck squamous cell carcinoma cells with stem cell properties.

  2013cited by this paper
• The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials

  2013cited by this paper
• Statistical and practical considerations for clinical evaluation of predictive biomarkers.

  2013cited by this paper
• The sox family of transcription factors: versatile regulators of stem and progenitor cell fate.

  2013cited by this paper
• Hypoxia Regulates CD44 and Its Variant Isoforms through HIF-1α in Triple Negative Breast Cancer

  2012cited by this paper
• CD98 at the crossroads of adaptive immunity and cancer

  2012cited by this paper
• The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

  2012cited by this paper
• Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors.

  2012cited by this paper
• Statistics corner: A guide to appropriate use of correlation coefficient in medical research.

  2012cited by this paper
• HIF induces human embryonic stem cell markers in cancer cells.

  2011cited by this paper
• The molecular biology of head and neck cancer

  2011influential reference
• Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

  2011cited by this paper
• Targeted Chemotherapy for Head and Neck Cancer with a Chimeric Oncolytic Adenovirus Coding for Bifunctional Suicide Protein FCU1

  2010cited by this paper
• Prognostic significance of Oct4 and Sox2 expression in hypopharyngeal squamous cell carcinoma

  2010cited by this paper
• Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Prognostic factors versus predictive factors: Examples from a clinical trial of erlotinib

  2008cited by this paper
• CD44-Epidermal Growth Factor Receptor Interaction Mediates Hyaluronic Acid-promoted Cell Motility by Activating Protein Kinase C Signaling Involving Akt, Rac1, Phox, Reactive Oxygen Species, Focal Adhesion Kinase, and MMP-2*

  2008cited by this paper
• Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma

  2007cited by this paper
• Hyaluronan-CD44 Interaction with Leukemia-associated RhoGEF and Epidermal Growth Factor Receptor Promotes Rho/Ras Co-activation, Phospholipase Cϵ-Ca2+ Signaling, and Cytoskeleton Modification in Head and Neck Squamous Cell Carcinoma Cells*

  2006cited by this paper
• Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.

  2006cited by this paper
• Nimotuzumab: evidence of clinical benefit without rash.

  2005cited by this paper
• CD98hc (SLC3A2) mediates integrin signaling.

  2005cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003cited by this paper
• Glycoprotein CD44 expression in benign, premalignant and malignant epithelial lesions of the larynx: an immunohistochemical study including correlation with Rb, p53, Ki-67 and PCNA.

  1999cited by this paper
• The normal structure and function of CD44 and its role in neoplasia.

  1998cited by this paper
• Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.

  1994cited by this paper
• Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.

  1994cited by this paper

• Evaluation of the Efficacy of Neoadjuvant Combined Therapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma

  2025cites this paper
• Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - a DAHANCA 19 study.

  2024cites this paper
• Population-Based Prognostic Models for Head and Neck Cancers Using National Cancer Registry Data from Taiwan

  2024cites this paper
• Hyperthermia for Targeting Cancer and Cancer Stem Cells: Insights from Novel Cellular and Clinical Approaches

  2024cites this paper
• miR‐199a/214 cluster enhances prostate cancer sensitiveness to nimotuzumab via targeting TBL1XR1

  2023cites this paper
• A state-of-the-art review on the NRF2 in Hepatitis virus-associated liver cancer

  2023cites this paper
• Advances in nanomaterials for the diagnosis and treatment of head and neck cancers: A review.

  2022cites this paper